INOmax (Mallinckrodt Pharmaceuticals)


Provider of integrated inhaled nitric oxide therapy including pharmaceutical gas production and cylinder distribution, bedside and transport-capable delivery and monitoring systems, clinical evidence for neonatal use, device operational documentation and training, and continuous clinical/technical support and emergency logistics.

Industries

Biotechnology
Pharmaceutical

Nr. of Employees

large (251-1000)

INOmax (Mallinckrodt Pharmaceuticals)


Patents

Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver no for inhalation therapy to a patient

US-12257391-B2

View Details

Systems and methods for delivery of therapeutic gas

US-12226572-B2

View Details

Systems and methods for manufacturing and safety of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient

US-11554242-B2

View Details

Systems and methods for delivery of therapeutic gas

US-11529479-B2

View Details

Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide

US-11141549-B2

View Details

Systems and methods for providing a pulse of a therapeutic gas with a desired flow profile to maximize therapeutic effectiveness

US-10758703-B2

View Details
View All Patents

Products

Cylinder-based pharmaceutical inhaled gas

Pharmaceutical-grade inhaled nitric oxide supplied in tested and inspected compressed-gas cylinders at defined concentrations and sizes, produced in a regulated facility with cylinder inspection and labeling.

Portable bedside and transport-capable inhaled gas delivery systems

Integrated delivery and monitoring systems designed for bedside use and intrahospital transport with automated pre-use checkout, redundant backups, alarms, data output and transport mounting features.

MRI-environment compatible delivery system variant

Device variant engineered for use near MRI scanners with MR-conditional components, magnetic-field alarms, extended circuit connections and specific consumable/ cylinder restrictions for MR-room use.

INOmax DSIR Plus

A proportional delivery system with a single electronic injector module (IM) designed to deliver constant concentration dosing of INOmax (nitric oxide) gas for inhalation through breath cycles and across ventilator modes in neonates.

INOmax DSIR® Plus MRI

The INOmax DSIR Plus MRI delivery system is MR Conditional and designed for use with MRI scanners of 1.5 or 3.0 Tesla strength in areas with field strength less than 100 gauss. It delivers INOmax (nitric oxide) gas for inhalation, indicated for neonates with HRF and pulmonary hypertension, for up to 14 days of use.

INOMAX (nitric oxide) gas

INOmax is a nitric oxide gas for inhalation indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension, used in conjunction with ventilatory support and other agents.

View All Products

Services

Continuous product, clinical and technical support for healthcare providers, including device troubleshooting, clinical specialist assistance and regional service center coordination.

Operational logistics for urgent delivery of inhaled gas cylinders, consumables and delivery systems with regional distribution and emergency-response procedures.

Customer reimbursement assistance through account-led guidance and access to billing-code resources for therapy-related services and products.

Live and virtual device-specific trainings and simulation-based tools for clinical staff covering device operation, pre-use checkout and clinical workflows.

Part-numbered catalogs and order forms for disposable components and accessory packs to support clinical maintenance and supply replenishment.

Expertise Areas

  • Inhaled gas therapy for neonatal hypoxic respiratory failure
  • Drug-device combination safety and MR-conditional device practices
  • Pharmaceutical gas filling and cylinder quality control
  • Clinical trial evidence generation and prescribing information management
  • Show More (3)

Key Technologies

  • Electrochemical gas sensors for NO, NO2 and O2
  • Closed-loop proportional-flow dosing and solenoid control
  • Pneumatic fixed-flow backup delivery
  • Automated calibration wizards (low and high range) with calibration gas inputs
  • Show More (6)

News & Updates

Double-blind, randomized, placebo-controlled multicenter trial demonstrating improved oxygenation and reduced need for ECMO in neonates treated with inhaled nitric oxide.

Randomized placebo-controlled multicenter study reporting reduced ECMO rates and improvements in oxygenation measures with inhaled nitric oxide in neonates with pulmonary hypertension and hypoxic respiratory failure.

Full prescribing information describing indications, dosing recommendations, warnings (rebound pulmonary hypertension, methemoglobinemia, NO2 monitoring) and clinical study summaries for inhaled nitric oxide in neonates.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.